LEADER 00000nam a2200301Ia 4500 |
001 13399126746 |
003 BCNR |
008 060524s2018 xxua b 001 0 eng d |
020 ^a9781260288322
|
060 04 ^aWH100^bW723 2018
|
245 00 ^aWilliams hematology :^bMalignant lymphoid diseases /^ceditors, Press,Oliver W.,Lichtman,Marshall A., &Leonard, John P
|
246 30 ^aMalignant lymphoid diseases
|
250 ^a1st ed.
|
260 ^aNew York :^bMcGraw-Hill, education,^c2018
|
300 ^axi, 340. :^bill. ;^c28 cm.
|
500 ^aPress,Oliver W.,Lichtman,Marshall A., &Leonard, John P (Ed). (2018). Williams hematology : Malignant lymphoid diseases. New York :McGraw-Hill, education.
|
504 ^aIncludes bibliographical references and index
|
505 0 ^aChapter 1: Classification of Malignant Lymphoid Disorders -- Chapter 2: Acute Lymphoblastic Leukemia -- Chapter 3: Chronic Lymphocytic Leukemia -- Chapter 4: Hairy Cell Leukemia -- Chapter 5: Large Granular Lymphocytic Leukemia -- Chapter 6: General Considerations oF Lymphomas: Epidemiology, Etiology, Heterogeneity, and Primary Extranodal Disease -- Chapter 7: Pathology of Lymphomas -- Chapter 8: Hodgkin Lymphoma -- Chapter 9: Diffuse Large B-Cell Lymphoma and Related Neoplasms -- Chapter 10: Follicular Lymphoma -- Chapter 11: Mantle Cell Lymphoma -- Chapter 12: Marginal Zone B-Cell Lymphomas -- Chapter 13: Burkitt Lymphoma -- Chapter 14: Cutaneous T-Cell Lymphoma (Mycosis Fungoides and S?zary Syndrome) -- Chapter 15: Mature T-Cell and Natural Killer Cell Lymphomas -- Chapter 16: Plasma Cell Neoplasms: General Considerations -- Chapter 17: Essential Monoclonal Gammopathy -- Chapter 18: Myeloma -- Chapter 19: Immunoglobulin Light-Chain Amyloidosis -- Chapter 20: Macroglobulinemia -- Chapter 21: Heavy-Chain Disease
|
650 2 ^aHematologic Diseases
|
700 1 ^aPress,Oliver W.,^eed.
|
700 1 ^aLichtman, Marshall A.,^eed.
|
700 1 ^aLeonard, John P.^eed.
|
999 ^aบรรณารักษ์
|